Complications of influenza and benefits of vaccination

Vaccine

Volumn 17, Issue SUPPL. 1, 1999, Pages

  Nichol, Kristin L ^a  

^a VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AGED; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG EFFICACY; FEMALE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PNEUMONIA; PRIORITY JOURNAL;

EID: 0033618370     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00105-X     Document Type: Conference Paper

References (31)

1. Nicholson KG, Snacken R, Palache AM. Influenza immunization policies in Europe and the United States. Vaccine 1995;13:365-9.
2. Fedson DS, Hirota Y, Shin HK, Cambillard PE, Kiely J, Ambrosch F, Hannoun C, Leese J, Sprenger MJ, Hampson AW, Bro-Jorgensen K, Ahlbom AM, Nokleby H, Valle M, Olafsson O, Salmeron F, Cloetta J, Rebelo de Andrade H, Snacken R, Donatteli I, Jennings LC, Strikas RA. Influenza vaccination in 22 developed countries: an update to 1995. Vaccine 1997;14:1506-11.
3. Margolis KL, Nichol KL, Wuorenma J, Von Sternberg TL. Exporting a successful influenza vaccination program from a teaching hospital to a community outpatient setting. J Am Geriatr Soc 1992;40:1021-3.
4. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331:778-84.
5. Nichol KL, Wuorenma J, Von Sternberg T The benefits of influenza vaccination for low, intermediate, and high risk seniors. Arch Intern Med 1998 158:1769-76.
6. Haddix AC, Teutsch SM, Shaffer PA, Dunet DO. In: Prevention effectiveness: a guide to decision analysis and economic evaluation. New York: Oxford University Press, 1996. p. 193-201.
7. Centers for Disease Control. Influenza surveillance - United States, 1989-90 and 1990-91 seasons. In CDC Surveillance Summaries, May 29, 1992. Morb Mortal Wkly Rep 1992 41(SS-3), 35-46.
8. Centers for Disease Control and Prevention. Influenza surveillance - United States, 1991-92. In CDC Surveillance Summaries, Sept 4, 1992; Morb Mortal Wkly Rep 1992 41(SS-5), 35-46.
9. Centers for Disease Control and Prevention. Influenza surveillance - United States, 1992-93 and 1993-94. In CDC Surveillance Summaries, Jan 31, 1997. Morb Mortal Wkly Rep 1997 46(SS-1), 1-12.
10. Centers for Disease Control and Prevention. Update: influenza activity - United States and worldwide, 1994-95 season, and composition of the 1995-96 influenza vaccine. Morb Mortal Wkly Rep 1995 44, 292-295.
11. Centers for Disease Control and Prevention. Update: influenza activity - United States and worldwide, 1995-96 season, and composition of the 1996-97 influenza vaccine. Morb Mortal Wkly Rep 1996 45, 326-329.
12. Mullooly JP, Bennett MD, Hornbrook MC, Barker WH, Williams WW, Patriarca PA, Rhodes PH. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994;121:947-52.
13. Fedson DS, Wajda A, Nicol JP, Hammond GW, Kaiser DL, Roos LL. Clinical effectiveness of influenza vaccination in Manitoba. JAMA 1993;270:1956-61.
14. Foster DA, Talsma A, Furumoto-Dawson A, et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992;136:296-307.
15. Ohmit SE, Monto AS. Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. Int J Epidemiol 1995;24:1240-8.
16. Puig-Barbera J, Marquez-Calderon S, Masoliver-Fores A, Lloria-Paes F, Ortega-Dicha A, Gil-Martin M, Calero-Martinez MJ. Reduction in hospital admission for pneumonia in noninstitutionalised elderly people as a result of influenza vaccination: a case-control study in Spain. J Epidemiol Community Health 1997;51:526-30.
17. Bonvehi P, Nacinovich F, Ruttimann R, Vujacich C, Giannone C, Stambouliah D. Effectiveness of influenza vaccine in elderly people living in the community in Argentina. In: Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology, 1997. p. 238 (abstract).
18. Fleming DM, Watson JM, Nicholas S, Smith GE, Swan AV. Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiol Infect 1995;115:581-9.
19. Centers for Disease Control and Prevention. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices. Morb Mortal Wkly Rep 1998 47(RR-6).
20. Ahmed AH, Nicholson KG, Nguyen-van T, Pearson JC. Effectiveness of influenza vaccination in reducing hospital admissions during the epidemic of 1989-90. Epidemiol Infection 1997;118:27-33.
21. Ahmed AEH, Nicholson KG, Nguyen-Van-Tam JS. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet 1995;346:591-5.
22. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995;123:518-27.
23. Honkanen PO, Keistinen T, Kivela SL. The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population. Vaccine 1997;15:317-20.
24. Maucher JM, Gambert SR. Cost-effective analysis of influenza vaccination in the elderly. Age 1990;13:3-9.
25. Centers for Disease Control and Prevention. Final results: Medicare influenza vaccine demonstration - selected states, 1988-1992. Morb Mortal Wkly Rep 1993 42, 601-4.
26. Helliwell BE, Drummond MF. The costs and benefits of preventing influenza in Ontario's elderly. Can J Public Health 1988;79:175-9.
27. Scott WG, Scott HM. Economic evaluation of vaccination against influenza in New Zealand. PharmacoEconomic 1996;9:51-60.
28. Riddiough MA, Sisk JE, Bell JC. Influenza vaccination. Cost-effectiveness and public policy. JAMA 1983;249:3189-95.
29. Russell LB. Opportunity costs in modern medicine. Health Affairs 1992;11:162-9.
30. Fedson DS Influenza and pneumococcal vaccination of the elderly: Newer vaccines and prospects for clinical benefits at the margin. Prev Med 1994 751-755.
31. Iezzoni LI. In: lezzoni LI, editor. Risk adjustment for measuring health care outcomes. Ann Arbor, MI: Health Administration Press, 1994. p. 1-28.